Patent · US Active

Heterologous expression of Neisserial proteins

US9150898B2 · kind B2 · utility

14Cited by
29References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2014
Grant dateOct 6, 2015
Priority date
Expiry dateJul 31, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Alternative and improved approaches to the heterologous expression of the proteins of Neisseria meningitidis and Neisseria gonorrhoeae are disclosed. These approaches typically affect the level of expression, the ease of purification, the cellular localization, and/or the immunological properties of the expressed protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.